- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03982355
Development and Validation of a Tumour Oxygenation Monitoring Probe
Studieoversigt
Detaljeret beskrivelse
Tumour hypoxia is feature common to most solid tumours, with significant implications in tumour aggressiveness, metastatic potential and response to therapy. Tumour oxygenation monitoring is likely, therefore, to provide a valuable adjunct in risk stratification and treatment response monitoring.
Diffuse reflectance spectroscopy (DRS) utilises the differing absorption of oxygenated as compared to deoxygenated haemoglobin to provide an accurate measure of tissue oxygenation.
This project aims to develop and validate a tissue oxygenation probe for cancer monitoring. Using the clinical paradigms of rectal and breast cancer, anonymised MRIs of cancer sufferers will guide simulations of tissue optical properties to develop a DRS probe. The 3D reconstructed sans will then be used to 3D print tissue phantom models on which the DRS probe will be validated against reference bench top analysers.
Undersøgelsestype
Tilmelding (Forventet)
Kontakter og lokationer
Studiesteder
-
-
Greater London
-
London, Greater London, Det Forenede Kongerige, W21NY
- Rekruttering
- Imperial College London
-
Kontakt:
- Simon D Dryden, MBChB, MPH
- Telefonnummer: 447828464949
- E-mail: simon.dryden@imperial.ac.uk
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- MRIs from Breast or Rectal Cancer patients (10 of each)
- Locally advanced Cancers (Stage 2 or 3)
- Patients who went on to receive neoadjuvant chemoradiotherapy.
- Anonymised scans
Exclusion Criteria:
- MRIs from patients under the age of 18, or older than 99 years old will be excluded.
- MRIs from patients who did not receive neoadjuvant therapy for cancer will be excluded.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Breast Cancer
Anonymised MRI scans (pre-therapy) of locally advanced breast cancer sufferers.
|
The Oxygenation measurements of the novel diffuse reflectance spectroscopy probe
|
Rectal Cancer
Anonymised MRI scans (pre-therapy) of locally advanced rectal cancer sufferers.
|
The Oxygenation measurements of the novel diffuse reflectance spectroscopy probe
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Oxygenation correlation
Tidsramme: During Intervention: The DRS probe (intervention) and reference (control) measurements will take place within one hour
|
Correlation of sensor oxygenation measurements as compared to gold-standard oxygenation measurements in phantom tissue models
|
During Intervention: The DRS probe (intervention) and reference (control) measurements will take place within one hour
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Forventet)
Studieafslutning (Forventet)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 19SM5221
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med DRS probe
-
Hospital for Special Surgery, New YorkConventus Orthopaedics, Inc.Afsluttet
-
Imperial College LondonCancer Research UK; National Institute for Health Research, United KingdomRekruttering
-
University Hospital, LilleRekrutteringNyretransplantationskandidat for højre nyre | Nyretransplantationskandidat for venstre nyreFrankrig
-
Assistance Publique - Hôpitaux de ParisParis-Saclay UniversityRekrutteringTraumatisk hjerneskade | Flere traumerFrankrig
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Ukendt
-
Shandong UniversityUkendt
-
University of FloridaAfsluttet
-
Memorial Sloan Kettering Cancer CenterRekrutteringEndometriecancerForenede Stater
-
University of California, Los AngelesMayo Clinic; Hacettepe University; All India Institute of Medical Sciences... og andre samarbejdspartnereAfsluttetSlagForenede Stater, Kalkun, Nigeria, Østrig, Tyskland, Indien, Italien, Japan, Korea, Republikken, Spanien
-
University of ArkansasRekruttering